Innate Pharma (IPHA) Selling, General & Administrative (2019 - 2026)
Innate Pharma (IPHA) posted Selling, General & Administrative of -$9.06 million for the quarter ended Jun 30, 2026, compared with -$11.06 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Selling, General & Administrative (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Innate Pharma was -$63.76 million; for the year ended Dec 31, 2025, it came in at -$21.91 million.
- In prior years, Innate Pharma's Selling, General & Administrative was -$21.34 million in the year ended Dec 31, 2024, -$19.78 million in the year ended Dec 31, 2023, -$23.65 million in the year ended Dec 31, 2022 and -$29.2 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Selling, General & Administrative in data going back to the quarter ended Jun 30, 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Innate Pharma | 152.76 Mn | 152.76 Mn | - | -9.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.06 Mn |
| Dec 31, 2025 | -22.58 Mn |
| Jun 30, 2025 | -11.06 Mn |
| Dec 31, 2024 | -21.07 Mn |
| Jun 30, 2024 | -10.32 Mn |
| Dec 31, 2023 | -19.68 Mn |
| Jun 30, 2023 | -9.96 Mn |
| Dec 31, 2022 | -22.89 Mn |
| Jun 30, 2022 | -12.95 Mn |
| Dec 31, 2021 | -29.20 Mn |
| Jun 30, 2021 | -23.27 Mn |
| Dec 31, 2020 | -22.64 Mn |
| Jun 30, 2020 | -15.96 Mn |
| Dec 31, 2019 | -28.56 Mn |
| Jun 30, 2019 | -10.44 Mn |
API Access
Innate Pharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();